CRISPR in the post-COVID Era

What has the global COVID-19 pandemic changed about the biotech industry in general, and CRISPR in particular? Dr. Jennifer Doudna, who co-discovered the revolutionary CRISPR-Cas9 gene editing technology, joins us to discuss the immediate and lasting implications of the novel coronavirus and transformations in genetic science.